Skip to content

Case Report in Complications After Laparoscopic Transabdominal Preperitoneal Groin Hernia Repair Using LiquiBandFIX8®

Laparoscopic Transabdominal Preperitoneal (TAPP) Groin Hernia Repair Using N-butyl-2-cyanoacrylate (LiquiBandFIX8®)for Mesh Fixation and Peritoneal Closure: Case Report About Extraperitoneal Hematoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05952791
Enrollment
1
Registered
2023-07-19
Start date
2022-01-05
Completion date
2022-01-05
Last updated
2023-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Groin Hernia

Brief summary

This an a case report about management and proving the strenght and resistance of LiquiBandFIX8® using for peritoneal closure in a laparoscopic transabdominal preperitoneal groin hernia repair. The patient had anticoagulation due to a mechanical valvula and postoperatively the patient developed a huge hematoma extraperitoneally. Relaparoscopy war performed to identify the problem and check the peritoneal closure.

Detailed description

This an a case report for proving the strenght and resistance of LiquiBandFIX8® using for peritoneal closure in a laparoscopic transabdominal preperitoneal groin hernia repair (TAPP). The patient had anticoagulation due to a mechanical valvula and postoperatively after TAPP the patient developed a huge hematoma extraperitoneally. The investigatorsperformed relaparoscopy for diagnostic and therapeutic reasons to check stop the bleeding and control the integrety of the peritoneal closure.

Interventions

OTHERSurgery

Laparoscopic transabdominal preperitoneal (TAPP) groin hernia repair

Sponsors

Kepler University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Retrospective case report of one patient undergoing laparoscopic groin hernia repair

Exclusion criteria

\- not applicable (retrospective)

Design outcomes

Primary

MeasureTime frameDescription
Strongness of LiquiBandFIX8®2 weeksMesh dislocation, mesh damage (yes/no)
Hemtoma2 weeksintraperitoneal blood (yes/no)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026